NASDAQ
Jazz Pharmaceuticals plc (JAZZ) has a price/fcf ratio of 7.99x as of Monday, May 25, 2026. This represents a 11.65% decrease compared to its 12-month average of 9.05x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.